Dasgupta A, Wells A, Datta P
Department of Pathology and Laboratory Medicine, University of Texas-Houston Medical School, 77030, USA.
J Clin Lab Anal. 2000;14(4):164-8. doi: 10.1002/1098-2825(2000)14:4<164::aid-jcla5>3.0.co;2-m.
Prostate specific antigen (PSA) is a glycoprotein found in the epithelial cells of the prostatic duct and acini. PSA is elevated in all four stages of prostate cancer as well as in benign prostatic hypertrophy. We evaluated a new chemiluminescent assay for PSA by comparing this assay with the microparticle enzyme immunoassay for PSA (MEIA) on the AxSYM analyzer (Abbott Laboratories, Abbott Park, IL) and a Hybritech Tandem R assay for PSA. The new chemiluminescent assay is recently available from Bayer Diagnostics (Tarrytown, NY) and can be run using the ACS: 180 Plus analyzer. Precision of the new chemiluminescent assay was evaluated using commercially available controls (Bayer Diagnostics). The within-run and total CVs were 6.4 and 8.7% for the low control (mean: 0.43 microg/L), 1.6 and 5.2% for the next level control (mean:1.94 mg/L), 4.3 and 4.9% for the medium control (mean: 2.10 mg/L), 1.2 and 3.9% for the high control 1 (mean: 11.52 mg/L), and finally 3.2 and 6.9% for the high control 2 (mean: 21.52 mg/L). The spike recovery varied from 94.2 to 109.6% for five different specimens we studied. We also observed excellent dilution recoveries. For example, in the specimen supplemented with 3.02 mg/L of PSA, the dilution recoveries were 102. 1, 104.7, and 103.7% for 1:2, 1:4, and 1:8 dilutions, respectively. We analyzed 113 serum specimens from patients with various concentrations of PSA (range 0.5 mg/L-2040 mg/L) using the new chemiluminescent assay and compared our results with the MEIA and Hybridtech (Tandem-R PSA) assays. Using x axis as the PSA concentrations obtained by the Tandem-R assay and the y axis as the PSA values obtained by the new chemiluminescent assay, we observed the following regression equations: y = 1.04 x -0.19 (r = 0.99, n = 112). One specimen with PSA concentrations of 2040 microg/L by the MEIA and 2156 microg/L by the chemiluminescent assay was not used for regression analysis. Similarly using x axis as the PSA concentrations obtained by the MEIA assay and y axis as the PSA concentrations obtained by the chemiluminescent assay, we observed the following regression equation: y = 0.88 + 0.02 (r = 0.99, n = 112). We conclude that the new chemiluminescent assay has excellent precision and the results compared well with the existing assays.
前列腺特异性抗原(PSA)是一种存在于前列腺导管和腺泡上皮细胞中的糖蛋白。在前列腺癌的所有四个阶段以及良性前列腺增生中,PSA水平都会升高。我们通过在AxSYM分析仪(雅培实验室,伊利诺伊州雅培公园)上,将这种新的化学发光法检测PSA与微粒酶免疫分析法(MEIA)检测PSA以及Hybritech Tandem R法检测PSA进行比较,对一种新的PSA化学发光检测法进行了评估。这种新的化学发光检测法最近可从拜耳诊断公司(纽约塔里敦)获得,并且可以使用ACS: 180 Plus分析仪进行检测。使用市售对照品(拜耳诊断公司)评估了新化学发光检测法的精密度。低浓度对照品(均值:0.43微克/升)的批内变异系数和总变异系数分别为6.4%和8.7%,下一个浓度水平对照品(均值:1.94毫克/升)的批内变异系数和总变异系数分别为1.6%和5.2%,中等浓度对照品(均值:2.10毫克/升)的批内变异系数和总变异系数分别为4.3%和4.9%,高浓度对照品1(均值:11.52毫克/升)的批内变异系数和总变异系数分别为1.2%和3.9%,最后,高浓度对照品2(均值:21.52毫克/升)的批内变异系数和总变异系数分别为3.2%和6.9%。对于我们研究的五个不同标本,加标回收率在94.2%至109.6%之间。我们还观察到了出色的稀释回收率。例如,在添加了3.02毫克/升PSA的标本中,1:2、1:4和1:8稀释度的稀释回收率分别为102.1%、104.7%和103.7%。我们使用新的化学发光检测法分析了113份来自不同PSA浓度(范围为0.5毫克/升 - 2040毫克/升)患者的血清标本,并将我们的结果与MEIA法和Hybridtech(Tandem - R PSA)法的结果进行了比较。以x轴为Tandem - R法获得的PSA浓度,y轴为新化学发光检测法获得的PSA值,我们观察到以下回归方程:y = 1.04x - 0.19(r = 0.99,n = 1)。通过MEIA法测得PSA浓度为2040微克/升且通过化学发光检测法测得为2156微克/升的一份标本未用于回归分析。同样,以x轴为MEIA法获得的PSA浓度,y轴为化学发光检测法获得的PSA浓度,我们观察到以下回归方程:y = 0.88 + 0.02(r = 0.99,n = 112)。我们得出结论,新的化学发光检测法具有出色的精密度,并且结果与现有检测法相比良好。 112
(注:原文中“r = 0.99, n = 1”应为“r = 0.99, n = 112”,译文已修正)